Jacqueline Scanlan Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jacqueline Scanlan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jacqueline Scanlan. Jacqueline Scanlan is SVP, Global Human Resources in HAEMONETICS CORP ($HAE) and SVP & CHRO in Axalta Coating Systems Ltd. ($AXTA).
Latest Insider Trading Transactions of Jacqueline Scanlan
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16 2021 | AXTA | Axalta Coating Sys ... | Scanlan Jacqueline | SVP & CHRO | Option Exercise | A | 0.00 | 8,620 | 0 | 8,620 | |
| Jun 16 2021 | AXTA | Axalta Coating Sys ... | Scanlan Jacqueline | SVP & CHRO | Option Exercise | A | 0.00 | 23,090 | 0 | 23,090 | |
| May 18 2021 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 55.97 | 102 | 5,709 | 4,523 | 4.6 K to 4.5 K (-2.21 %) |
| Mar 10 2021 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 120.07 | 107 | 12,847 | 4,380 | 4.5 K to 4.4 K (-2.38 %) |
| Jun 16 2020 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Option Exercise | M | 41.64 | 2,889 | 120,298 | 2,890 | |
| Jun 16 2020 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 91.53 | 6,869 | 628,720 | 4,487 | 11.4 K to 4.5 K (-60.49 %) |
| Jun 16 2020 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 90.00 | 4,005 | 360,450 | 11,356 | 15.4 K to 11.4 K (-26.07 %) |
| Jun 16 2020 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Buy | M | 41.64 | 2,889 | 120,298 | 15,361 | 12.5 K to 15.4 K (+23.16 %) |
| Jun 16 2020 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 87.71 | 4,417 | 387,415 | 12,472 | 16.9 K to 12.5 K (-26.15 %) |
| Jun 16 2020 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 89.29 | 111 | 9,911 | 16,889 | 17 K to 16.9 K (-0.65 %) |
| Jun 16 2020 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Grant | A | 0.00 | 11,286 | 0 | 17,000 | 5.7 K to 17 K (+197.51 %) |
| Jun 10 2020 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 97.03 | 324 | 31,438 | 5,714 | 6 K to 5.7 K (-5.37 %) |
| May 19 2020 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Option Exercise | A | 103.37 | 5,319 | 549,825 | 5,319 | |
| May 19 2020 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Grant | A | 0.00 | 1,572 | 0 | 6,038 | 4.5 K to 6 K (+35.20 %) |
| May 19 2020 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 100.44 | 110 | 11,048 | 4,466 | 4.6 K to 4.5 K (-2.40 %) |
| Mar 10 2020 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Option Exercise | M | 38.43 | 1,299 | 49,921 | 1,300 | |
| Mar 10 2020 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Option Exercise | M | 38.43 | 1,299 | 49,921 | 1,300 | |
| Mar 10 2020 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 99.63 | 207 | 20,623 | 4,383 | 4.6 K to 4.4 K (-4.51 %) |
| Mar 10 2020 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 99.63 | 207 | 20,623 | 4,383 | 4.6 K to 4.4 K (-4.51 %) |
| Mar 10 2020 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 98.00 | 118 | 11,564 | 4,590 | 4.7 K to 4.6 K (-2.51 %) |
| Mar 10 2020 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 98.00 | 118 | 11,564 | 4,590 | 4.7 K to 4.6 K (-2.51 %) |
| Mar 10 2020 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 100.50 | 1,299 | 130,550 | 4,708 | 6 K to 4.7 K (-21.62 %) |
| Mar 10 2020 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 100.50 | 1,299 | 130,550 | 4,708 | 6 K to 4.7 K (-21.62 %) |
| Mar 10 2020 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Buy | M | 38.43 | 1,299 | 49,921 | 6,007 | 4.7 K to 6 K (+27.59 %) |
| Mar 10 2020 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Buy | M | 38.43 | 1,299 | 49,921 | 6,007 | 4.7 K to 6 K (+27.59 %) |
| Oct 10 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 124.61 | 1,379 | 171,837 | 4,695 | 6.1 K to 4.7 K (-22.70 %) |
| Oct 10 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 123.57 | 1,230 | 151,991 | 6,074 | 7.3 K to 6.1 K (-16.84 %) |
| Oct 10 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 122.37 | 300 | 36,711 | 7,304 | 7.6 K to 7.3 K (-3.95 %) |
| Oct 10 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 122.34 | 2,295 | 280,770 | 7,604 | 9.9 K to 7.6 K (-23.18 %) |
| Oct 08 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Grant | A | 0.00 | 5,204 | 0 | 9,899 | 4.7 K to 9.9 K (+110.84 %) |
| Oct 08 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Grant | A | 0.00 | 5,204 | 0 | 9,899 | 4.7 K to 9.9 K (+110.84 %) |
| Sep 11 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Option Exercise | M | 93.52 | 1,308 | 122,324 | 3,925 | |
| Sep 11 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 127.44 | 1,531 | 195,111 | 4,695 | 6.2 K to 4.7 K (-24.59 %) |
| Sep 11 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Buy | M | 93.52 | 1,308 | 122,324 | 6,226 | 4.9 K to 6.2 K (+26.60 %) |
| Jun 18 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Option Exercise | M | 41.64 | 2,890 | 120,340 | 5,779 | |
| Jun 18 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 112.49 | 259 | 29,135 | 4,918 | 5.2 K to 4.9 K (-5.00 %) |
| Jun 18 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 112.49 | 497 | 55,908 | 5,177 | 5.7 K to 5.2 K (-8.76 %) |
| Jun 18 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 112.49 | 2,890 | 325,096 | 5,674 | 8.6 K to 5.7 K (-33.75 %) |
| Jun 18 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Buy | M | 41.64 | 2,890 | 120,340 | 8,564 | 5.7 K to 8.6 K (+50.93 %) |
| Jun 13 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 109.37 | 108 | 11,812 | 5,674 | 5.8 K to 5.7 K (-1.87 %) |
| Jun 10 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 103.38 | 208 | 21,503 | 5,782 | 6 K to 5.8 K (-3.47 %) |
| May 16 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Option Exercise | A | 98.03 | 5,342 | 523,650 | 5,342 | |
| May 16 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Option Exercise | M | 38.43 | 1,299 | 49,921 | 2,599 | |
| May 16 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Grant | A | 0.00 | 1,530 | 0 | 5,990 | 4.5 K to 6 K (+34.30 %) |
| May 16 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 100.00 | 1,508 | 150,800 | 4,237 | 5.7 K to 4.2 K (-26.25 %) |
| May 16 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Buy | M | 38.43 | 1,299 | 49,921 | 5,745 | 4.4 K to 5.7 K (+29.22 %) |
| Mar 11 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 83.57 | 116 | 9,694 | 4,446 | 4.6 K to 4.4 K (-2.54 %) |
| Dec 14 2018 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 104.22 | 1,027 | 107,034 | 4,562 | 5.6 K to 4.6 K (-18.38 %) |
| Sep 12 2018 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Option Exercise | M | 41.64 | 2,889 | 120,298 | 8,669 | |
| Sep 12 2018 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Option Exercise | M | 38.43 | 1,299 | 49,921 | 3,898 | |
| Sep 12 2018 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 112.19 | 702 | 78,757 | 5,551 | 6.3 K to 5.6 K (-11.23 %) |
| Sep 12 2018 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 112.19 | 2,889 | 324,117 | 6,253 | 9.1 K to 6.3 K (-31.60 %) |
| Sep 12 2018 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Buy | M | 41.64 | 2,889 | 120,298 | 9,142 | 6.3 K to 9.1 K (+46.20 %) |
| Sep 12 2018 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 112.19 | 1,299 | 145,735 | 6,253 | 7.6 K to 6.3 K (-17.20 %) |
| Sep 12 2018 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Buy | M | 38.43 | 1,299 | 49,921 | 7,552 | 6.3 K to 7.6 K (+20.77 %) |
| Jun 13 2018 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Option Exercise | A | 93.52 | 5,233 | 489,390 | 5,233 | |
| Jun 13 2018 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Grant | A | 0.00 | 1,470 | 0 | 6,253 | 4.8 K to 6.3 K (+30.73 %) |
| Jun 08 2018 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 92.73 | 214 | 19,844 | 4,783 | 5 K to 4.8 K (-4.28 %) |
| Mar 08 2018 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 72.23 | 114 | 8,234 | 4,524 | 4.6 K to 4.5 K (-2.46 %) |
Page: 1